Interviews

Alexander Gebauer from Galimedix Therapeutics talks to Pharmafocus about the link between the two diseases and what the treatment landscape for both could look like in the future

Ameet Nathwani at Dewpoint Therapeutics considers the current treatment landscape for both type 1 and type 2 diabetes, as well as evaluating the use of biomolecular condensates as a potential treatment option

Stefan Woxström at AstraZeneca Europe and Canada tells Pharmafocus about the link between climate change and human health, as well as considering how the pharma industry has contributed to the climate crisis

Pharmafocus talks to Scott Curley about the risks of CVD and the imporance of getting the right treatment at the right time

Professor Henrik Van Poppel, member of the expert group for the Let's Talk Prostate Cancer initiative tells Pharmafocus about its new campaign

Professor Rieke Alten, Head of the Department of Internal Medicine at Schlosspark-Klinik, illuminates the benefits of subcutaneous infliximab in treating rheumatoid arthritis

Doina Ionescu, General Manager at Merck, UK & Ireland, explores the importance of personalised healthcare and supported self-management, and highlights the work that Merck is doing in these areas

Hilary Rose shares her experience of living with Chronic Kidney Disease, and sheds light on the realities of stigma, diagnosis, and daily challenges for those living with the long-term condition